Literature DB >> 3145875

In vitro evaluation of ramoplanin (MDL 62198, A 16686)

S Dixson, W Brumfitt, J M Hamilton-Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3145875     DOI： 10.1007/bf01975062

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  Comparative in-vitro activity of LY146032 and eight other antibiotics against gram-positive bacteria isolated from children.

Authors:  M W Kline; E O Mason; S L Kaplan; L B Lamberth; G S Johnson
Journal:  J Antimicrob Chemother       Date:  1987-08       Impact factor: 5.790

2.  In vitro activity of A-16686, a new glycopeptide.

Authors:  H C Neu; N M Neu
Journal:  Chemotherapy       Date:  1986       Impact factor: 2.544

3.  Virginiamycin: nomenclature.

Authors:  P Crooy; R De Neys
Journal:  J Antibiot (Tokyo)       Date:  1972-06       Impact factor: 2.649

4.  A-16686, a new antibiotic from Actinoplanes. II. Biological properties.

Authors:  R Pallanza; M Berti; R Scotti; E Randisi; V Arioli
Journal:  J Antibiot (Tokyo)       Date:  1984-04       Impact factor: 2.649

5.  In vitro activity of A-16686, a potential antiplaque agent.

Authors:  R Pallanza; R Scotti; G Beretta; B Cavalleri; V Arioli
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

6.  A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics.

Authors:  B Cavalleri; H Pagani; G Volpe; E Selva; F Parenti
Journal:  J Antibiot (Tokyo)       Date:  1984-04       Impact factor: 2.649
  6 in total
  4 in total

1.  Pharmacological properties of NAI-603, a well-tolerated semisynthetic derivative of ramoplanin.

Authors:  Daniela Jabes; Cristina Brunati; GianPaolo Candiani; Simona Riva; Gabriella Romanó; Sonia Maffioli; Rosaria Rossi; Matteo Simone; Eleonora Gaspari; Stefano Donadio
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

2.  In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.

Authors:  T Lawrence; C Rotstein; T R Beam; E A Gorzynski; D Amsterdam
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

3.  Ramoplanin susceptibility testing criteria.

Authors:  A L Barry; M A Pfaller; P C Fuchs
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

4.  In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.

Authors:  F Biavasco; E Manso; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.